These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18806609)

  • 21. Angiotensin-converting enzyme inhibitor suppresses activation of calcineurin in renovascular hypertensive rats.
    Sheng H; Zhu J; Wu X; Yang D; Zhang J
    Hypertens Res; 2007 Dec; 30(12):1247-54. PubMed ID: 18344631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular B1 kinin receptors in patients with congestive heart failure.
    Lang NN; Cruden NL; Tse GH; Bloomfield P; Ludlam CA; Fox KA; Newby DE
    J Cardiovasc Pharmacol; 2008 Nov; 52(5):438-44. PubMed ID: 19033823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute exercise protects against doxorubicin cardiotoxicity.
    Wonders KY; Hydock DS; Schneider CM; Hayward R
    Integr Cancer Ther; 2008 Sep; 7(3):147-54. PubMed ID: 18815146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increases of kinin B1 and B2 receptors binding sites after brain infusion of amyloid-beta 1-40 peptide in rats.
    Viel TA; Lima Caetano A; Nasello AG; Lancelotti CL; Nunes VA; Araujo MS; Buck HS
    Neurobiol Aging; 2008 Dec; 29(12):1805-14. PubMed ID: 17570564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of lycopene on doxorubicin-induced cardiotoxicity: an echocardiographic, histological and morphometrical assessment.
    Anjos Ferreira AL; Russell RM; Rocha N; Placido Ladeira MS; Favero Salvadori DM; Oliveira Nascimento MC; Matsui M; Carvalho FA; Tang G; Matsubara LS; Matsubara BB
    Basic Clin Pharmacol Toxicol; 2007 Jul; 101(1):16-24. PubMed ID: 17577311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin.
    Montenegro MF; Pessa LR; Tanus-Santos JE
    Eur J Pharmacol; 2009 Apr; 607(1-3):173-7. PubMed ID: 19233159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Both B1R and B2R act as intermediate signaling molecules in high glucose-induced stimulation of glutamate uptake in ARPE cells.
    Lim SK; Han HJ; Kim KY; Park SH
    J Cell Physiol; 2009 Dec; 221(3):677-87. PubMed ID: 19725054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function.
    Erdös EG; Tan F; Skidgel RA
    Hypertension; 2010 Feb; 55(2):214-20. PubMed ID: 20065150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of angiotensin-converting enzyme inhibitors on systemic inflammation and myocardial sympathetic innervation in normotensive patients with type 2 diabetes mellitus.
    Marketou ME; Zacharis EA; Koukouraki S; Stathaki MI; Arfanakis DA; Kochiadakis GE; Chlouverakis G; Karkavitsas NS; Vardas PE
    J Hum Hypertens; 2008 Mar; 22(3):191-6. PubMed ID: 18046434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blockade of sensory abnormalities and kinin B(1) receptor expression by N-acetyl-L-cysteine and ramipril in a rat model of insulin resistance.
    Ismael MA; Talbot S; Carbonneau CL; Beauséjour CM; Couture R
    Eur J Pharmacol; 2008 Jul; 589(1-3):66-72. PubMed ID: 18555989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enalapril treatment corrects the reduced response to bradykinin in diabetes increasing the B2 protein expression.
    Rastelli VM; Oliveira MA; dos Santos R; de Cássia Tostes Passaglia R; Nigro D; de Carvalho MH; Fortes ZB
    Peptides; 2008 Mar; 29(3):404-11. PubMed ID: 18190998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac chymase converts rat proAngiotensin-12 (PA12) to angiotensin II: effects of PA12 upon cardiac haemodynamics.
    Prosser HC; Forster ME; Richards AM; Pemberton CJ
    Cardiovasc Res; 2009 Apr; 82(1):40-50. PubMed ID: 19147651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic supplementation of creatine and vitamins C and E increases survival and improves biochemical parameters after Doxorubicin treatment in rats.
    Santos RV; Batista ML; Caperuto EC; Costa Rosa LF
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1294-9. PubMed ID: 17973871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of kinin B1 receptor and oxidative stress in sensory abnormalities and arterial hypertension in an experimental rat model of insulin resistance.
    Lungu C; Dias JP; França CE; Ongali B; Regoli D; Moldovan F; Couture R
    Neuropeptides; 2007 Dec; 41(6):375-87. PubMed ID: 17988733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of doxorubicin tissue toxicity: does amifostine provide chemoprotection? An experimental study.
    Rigatos SK; Stathopoulos GP; Dontas I; Perrea-Kotsarelis D; Couris E; Karayannacos PE; Deliconstantinos G
    Anticancer Res; 2002; 22(1A):129-34. PubMed ID: 12017274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malaria infection promotes a selective expression of kinin receptors in murine liver.
    Ventura PDS; Carvalho CPF; Barros NMT; Martins-Silva L; Dantas EO; Martinez C; Melo PMS; Pesquero JB; Carmona AK; Nagaoka MR; Gazarini ML
    Malar J; 2019 Jun; 18(1):213. PubMed ID: 31234939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aliskiren attenuates myocardial apoptosis and oxidative stress in chronic murine model of cardiomyopathy.
    Rashikh A; Ahmad SJ; Pillai KK; Kohli K; Najmi AK
    Biomed Pharmacother; 2012 Mar; 66(2):138-43. PubMed ID: 22386366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of enalaprilat on cardiotoxicity induced by doxorubicin].
    Santos JM; Luna Filho B; Simões MJ; Moura OA; Ferreira C; Martinez Filho EE; Bocanegra JA
    Arq Bras Cardiol; 1996 Oct; 67(4):237-41. PubMed ID: 9181721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of 3-thienylalanine-ornithine-proline, new sulfur-containing angiotensin-converting enzyme inhibitor on blood pressure and oxidative stress in spontaneously hypertensive rats.
    Hanif K; Snehlata ; Pavar MC; Arif E; Biswas P; Fahim M; Pasha MA; Pasha S
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):145-50. PubMed ID: 19188834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blockade of bradykinin B2 receptor more effectively reduces postischemic blood-brain barrier disruption and cytokines release than B1 receptor inhibition.
    Su J; Cui M; Tang Y; Zhou H; Liu L; Dong Q
    Biochem Biophys Res Commun; 2009 Oct; 388(2):205-11. PubMed ID: 19647718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.